Erythromycin, 2'-(ethyl butanedioate)
CAS: 1264-62-6
Ref. AN-AG000SQT
1g | Descontinuado | ||
5g | Descontinuado | ||
25g | Descontinuado | ||
100mg | Descontinuado | ||
250mg | Descontinuado |
Informação sobre produto
Nome:
Erythromycin, 2'-(ethyl butanedioate)
Sinónimos:
- [u'E-Mycin E', u'EMycin E', u'EryPed', u'Erythromycin Ethylsuccinate', u'Erythroped', u'Ethyl Succinate, Eyrthromycin', u'Ethylsuccinate, Erythromycin', u'Eyrthromycin Ethyl Succinate', u'Monomycin', u'Pediamycin', u'Succinate, Eyrthromycin Ethyl', u'Wyamycin E', u'erythromycin ethylsuccinate', u'Erythroped', u'Pediamycin', u'Wyamycin E', u'EryPed', u'1264-62-6', u'Erythrocin ethyl succinate', u'E-Mycin E', u'Erythromycin ethyl succinate', u"Erythromycin 2'-(ethyl succinate)", u'ERY-PED', u'PEDIAMYCIN 400', u'E.E.S', u'Erythromycin, ethyl succinate', u'UNII-1014KSJ86F', u'MLS001074901', u'HSDB 3075', u'C43H75NO16', u'Erythromycin, mono(ethyl succinate)', u'EINECS 215-033-8', u'BRN 0077638', u'Erythromycin, mono(ethyl succinate) (ester)', u'CHEBI:31555', u'1014KSJ86F', u'Succinic acid, monoethyl ester, monoester with erythromycin', u'SMR000058868', u'succinicacid,monoethylester,monoesterwitherythromycin', u'EES Granules', u'EES (Antiobiotic)', u'Eyrthromycin Ethyl Succinate', u'Wyamycin', u'E.E.S.', u'Erythromycin ethylsuccinate [JAN]', u'NCGC00183038-01', u'41342-53-4', u'E-Mycin-E', u'E.E.S 200', u'E.E.S 400', u'Eryped (TN)', u'Erythrocin W (TN)', u'Erythromycin ethylsuccinate [USP:JAN]', u'erythrocinethylsuccinate', u'Spectrum_001046', u'AC1L9FGS', u'Spectrum2_000983', u'Spectrum3_000419', u'Spectrum4_000536', u'Spectrum5_000668', u'erythromycin-ethylsuccinate', u'DSSTox_CID_2993', u'Erythromycin-ethyl succinate', u'DSSTox_RID_76821', u'DSSTox_GSID_22993', u'Erythromycin A Ethylsuccinate', u'SCHEMBL18259', u'BSPBio_001978', u'KBioGR_001171', u'KBioSS_001526', u'4-18-00-07416 (Beilstein Handbook Reference)', u'MLS000028651', u'MLS001076672', u'DivK1c_000764', u'SPECTRUM1500279', u'SPBio_001045', u'cid_443953', u'CHEMBL1200688', u'DTXSID4022993', u'erythromycin,mono(ethylsuccinate)', u'BDBM96262', u'E.E.S. (TN)', u'HMS502G06', u'KBio1_000764', u'KBio2_001526', u'KBio2_004094', u'KBio2_006662', u'KBio3_001198', u'NINDS_000764', u'NSYZCCDSJNWWJL-YXOIYICCSA-N', u'HMS1923I21', u'HMS2091D03', u'Pharmakon1600-01500279', u'ERITHROMYCIN ETHYL SUCCINATE', u'HY-B0957', u"2'-(Ethyl butanedioate)erythromycin", u'Tox21_113497', u'CCG-40201', u'LMPK05000001', u'MFCD00084692', u'NSC756758', u's4060', u'AKOS008145410', u'ZINC169356230', u'CS-4434', u'E.E.S. 200', u'E.E.S. 400', u'MCULE-3725545409', u'NSC-756758', u'Erythromycin ethylsuccinate (JP17/USP)', u'erythromycin,mono(ethylsuccinate)(ester)', u'IDI1_000764', u'NCGC00021382-03', u'CPD000058868', u'SAM002548941', u'CAS-1264-62-6', u'Erythromycin mono(ethyl succinate) (ester)', u'SBI-0051367.P003', u'LS-147492', u'C12796', u'D01361', u'AB00051980_11', u'AB00051980_12', u'SR-05000001617', u'SR-05000001617-1', u'Succinic acid monoethyl ester monoester with erythromycin', u'oxo-oxacyclotetradec-6-yl]oxy]-6-methyloxan-3-yl] 1-O-ethyl butanedioate', u'(2S,3R,4S,6R)-4-(dimethylamino)-2-(((3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-14-ethyl-7,12,13-trihydroxy-4-(((2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyltetrahydro-2H-pyran-2-yl)oxy)-3,5,7,9,11,13-hexamethyl-2,10-dioxooxacyclotetradecan-6-yl)oxy)-6-methyltetrahydro-2H-pyran-3-yl ethyl succinate']
- (2R,3S,4R,6S)-4-(dimethylamino)-2-{[(3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-14-ethyl-7,12,13-trihydroxy-4-{[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyltetrahydro-2H-pyran-2-yl]oxy}-3,5,7,9,11,13-hexamethyl-2,10-dioxooxacyclotetradecan-6-yl]oxy}-6-methyltetrahydro-2H-pyran-3-yl ethyl butanedioate (non-preferred name)
- (3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-6-[(2S,3R,4S,6R)-4-dimethylamino-3-hydroxy-6-methyl-tetrahydropyran-2-yl]oxy-14-ethyl-7,12,13-trihydroxy-4-[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyl-tetrahydropyran-2-yl]oxy-3,5,7,9,11,13-hexamethyl-1-oxacyclotetradecane-2,10-dione
- 4-(dimethylamino)-2-({14-ethyl-7,12,13-trihydroxy-4-[(5-hydroxy-4-methoxy-4,6-dimethyltetrahydro-2H-pyran-2-yl)oxy]-3,5,7,9,11,13-hexamethyl-2,10-dioxooxacyclotetradecan-6-yl}oxy)-6-methyltetrahydro-2H-pyran-3-yl ethyl butanedioate (non-preferred name)
- 4-Ethoxy-4-Oxo-Butanoate
- Anamycin
- Arpimycin
- Durapaediat
- E-Mycin e
- Eritrocina
- Ver mais sinónimos
- EryPed
- Eryliquid
- Erythro ES
- Erythro-Holz
- Erythrocin ethyl succinate
- Erythromycin Ethly Succinate.
- Erythromycin Ethyl Succinate
- Erythromycin Ethylsuccinate
- Erythromycin, 2′-(ethyl butanedioate)
- Erythromycin, 2′-(ethyl succinate)
- Erythromycin, mono(ethyl succinate) (ester)
- Erythroped
- Esinol
- Evesin
- Monomycin
- Oxacyclotetradecane, erythromycin deriv.
- Paediathrocin
- Pediamycin
- Refkas
- Sigapedil
- Succinic acid, ethyl ester, monoester with erythromycin
- Wyamycin E
CAS:
Marca:
Indagoo
Armazenamento a longo prazo:
Notas:
Propriedades químicas
Peso molecular:
862.0527
Fórmula:
C43H75NO16
Cor/forma:
Solid
InChI:
InChI=1S/C43H75NO16/c1-15-29-43(11,52)36(48)24(5)33(47)22(3)20-41(9,51)38(25(6)34(26(7)39(50)57-29)59-32-21-42(10,53-14)37(49)27(8)56-32)60-40-35(28(44(12)13)19-23(4)55-40)58-31(46)18-17-30(45)54-16-2/h22-29,32,34-38,40,48-49,51-52H,15-21H2,1-14H3/t22-,23-,24+,25+,26-,27+,28+,29-,32+,34+,35-,36-,37+,38-,40+,41-,42-,43-/m1/s1
Chave InChI:
NSYZCCDSJNWWJL-YXOIYICCSA-N
MDL:
Ponto de fusão:
Ponto de ebulição:
Ponto de inflamação:
Densidade:
Concentração:
EINECS:
Merck:
Código HS: